Intensification of type 2 diabetes (T2DM) treatment with GLP-1 receptor agonists (GLP-1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP-1RA treatment.
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study / Petroni, Maria Letizia; Montesi, Luca; Colosimo, Santo; Caletti, Maria Turchese; Mazzotti, Arianna; Marchesini, Giulio. - In: ENDOCRINOLOGY, DIABETES & METABOLISM. - ISSN 2398-9238. - ELETTRONICO. - 2:4(2019), pp. e00082.1-e00082.8. [10.1002/edm2.82]
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study
Petroni, Maria Letizia;Montesi, Luca;Colosimo, Santo;Mazzotti, Arianna;Marchesini, Giulio
2019
Abstract
Intensification of type 2 diabetes (T2DM) treatment with GLP-1 receptor agonists (GLP-1RAs) promotes weight loss. We aimed to determine the synergistic effect of behavioural programmes on body weight on top of GLP-1RA treatment.| File | Dimensione | Formato | |
|---|---|---|---|
|
Petroni EDM2-2-e00082.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
768.38 kB
Formato
Adobe PDF
|
768.38 kB | Adobe PDF | Visualizza/Apri |
|
edm282-sup-0001-tables1.docx
accesso aperto
Descrizione: Supporting Information
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione
13.98 kB
Formato
Microsoft Word XML
|
13.98 kB | Microsoft Word XML | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
